IL-1β and IL-1ra are key regulators of the inflammatory response to RNA vaccines
Ira Mellman(Unknown), Lélia Delamarre(Genesys (United States)), Weilan Ye, Mahesh Yadav(University of Florida), Cecile de la Cruz, Patricia Himmels(Molecular Oncology (United States)), Andrés Paler-Martı́nez, Emily Freund(Stanford University), Jaehak Oh(Amgen (United States)), Craig Blanchette(Switch), Ann-Jay Tong(University of California, Los Angeles), Benjamin Haley, Zhainib Adel Amir, Sara Wichner, Uğur Şahin(Johannes Gutenberg University Mainz), Siri Tähtinen, Mark J. McCarron, Leesun Kim(Ulsan National Institute of Science and Technology), Jill Schartner(University of Wisconsin–Madison), Yoko Oei
Cited by 1
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
mRNA-based therapeutics — developing a new class of drugs
|Nature Reviews Drug Discovery|2014|2.4k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k